Modern Biopharmaceuticals: Design, Development and Optimization

王朝导购·作者佚名
 
Modern Biopharmaceuticals: Design, Development and Optimization  点此进入淘宝搜索页搜索
  特别声明:本站仅为商品信息简介,并不出售商品,您可点击文中链接进入淘宝网搜索页搜索该商品,有任何问题请与具体淘宝商家联系。
  参考价格: 点此进入淘宝搜索页搜索
  分类: 图书,进口原版,Medicine(医学),Pharmacology(药理学),Pharmacy,
  品牌: J?rg Kn?blein

基本信息出版社:Wiley-VCH; 1 (2005年12月5日)精装:2022页正文语种:英语ISBN:352731184X条形码:9783527311842商品尺寸:12.2 x 17 x 24 cm商品重量:3.9 KgASIN:352731184X商品描述内容简介Due to the impressive accumulation of out-standing results, presented by brilliant, privileged and creative thinkers, this unique book reads like the ‘Who is Who’ of biotechnology. Never before has such an impressive group of individuals contributed to one biotechnology book, including Nobel Prize laureates Robert Huber, Thomas R. Cech, and Manfred Eigen as well as authors from the world's most famous academic institutes and biotech companies, such as ETH Zurich, MIT, Stanford, Yale, Princeton, Harvard Medical School, Max-Planck-Institute, Fraunhofer-Institute, Moscow Academy of Sciences, London Imperial College and Baxter, Invitrogen, MorphoSys, Roche, and Schering AG.Published as a comprehensive four volume set, this title also includes a CD-ROMcontaining additional information and videos.Modern Biopharmaceuticals describes:THE FIRST cloned human embryoTHE FIRST myocardial regeneration with embryonic stem cellsTHE FIRST artificial kidneyTHE FIRST biopharmaceutical from a transgenic animalTHE FIRST individualized medicineTHE FIRST plasma-free Factor VIIITHE FIRST approved human cell lineTHE FIRST oral insulin, etc.“... an outstanding collection of articles from groundbreaking scientists, comprehensively describing the many novel ways cells are being deployed toward human good ...” James D. Watson, “DNA Codebreaker” & Nobel Prize Laureate (Physiology or Medicine, 1962)Modern Biopharmaceuticals is an essential reference work for biotechnologists, clinicians, medical doctors, pharmacists, pharmaceutical chemists, bio-chemists, molecular biologists, medicinal chemists, as well as all those working in the biotechnological and pharmaceutical industries, or medicinal institutes.作者简介Dr. Jörg Knäblein studied Biotechnolgy / Chemical Engineering. at the Society for Biotechnology Research (GBF) in Braunschweig, Germany and Biochemistry at the Max-Planck-Institute for Biochemistry. He received his Ph.D. from the Max-Planck-Institute for Biochemistry in Martinsried / Munich where he worked in the group of Professor Huber (Nobelprize laureate in 1988).

AWARDS:

Riedel-de Haen-Stiftung

Government / Ministery of science

Nomination for the Max-Buchner-Award from DECHEMA (Society for Biotechnolgy and Chemical Engineering)

Winner of the McKinsey business plan contest

 
 
免责声明:本文为网络用户发布,其观点仅代表作者个人观点,与本站无关,本站仅提供信息存储服务。文中陈述内容未经本站证实,其真实性、完整性、及时性本站不作任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
© 2005- 王朝网络 版权所有